Key topics addressed were margin compression, 340B opportunities, new retail margin opportunities, labor concerns, pharmacist recruitment and driving state policies.
The new Congressional Domestic Pharmaceutical Manufacturing Caucus will work to ensure a resilient supply chain of key medicines are manufactured in the United States to strengthen national security.